TickerFactsScreenerDevelopers

Fulgent Genetics, Inc. (FLGT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2014: -$4.40M2015: -$969.0K2016: $4.41M2017: $1.33M2018: -$675.0K2019: $5.52M2020: $140.63M2021: $538.58M2022: $253.52M2023: $27.00M2024: $21.06M2025: -$101.64M-$101.64M
2014Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$101.64M-582.6%
2024$21.06M-22.0%
2023$27.00M-89.3%
2022$253.52M-52.9%
2021$538.58M+283.0%
2020$140.63M+2449.0%
2019$5.52M+917.3%
2018-$675.0K-150.7%
2017$1.33M-69.8%
2016$4.41M+554.6%
2015-$969.0K+78.0%
2014-$4.40M—